Efficacy News and Research

RSS
EpiVax receives grant for $390,000 to optimize HIV vaccine delivery

EpiVax receives grant for $390,000 to optimize HIV vaccine delivery

Ceregene announces data from phase 2 clinical trial of CERE-120 for Parkinson's

Ceregene announces data from phase 2 clinical trial of CERE-120 for Parkinson's

Study looks at amount of time single mothers are able to give their children

Study looks at amount of time single mothers are able to give their children

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

AIDS advocates tell WHO: Stop harmful single-dose treatment for expectant mothers and infants

AIDS advocates tell WHO: Stop harmful single-dose treatment for expectant mothers and infants

Novel device enhances efficacy of standard chemotherapy

Novel device enhances efficacy of standard chemotherapy

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

FDA accepts Labopharm's NDA for formulation of trazodone

FDA accepts Labopharm's NDA for formulation of trazodone

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

Long-term use of a macrolide antibiotic reduce COPD exacerbations, raise questions

Long-term use of a macrolide antibiotic reduce COPD exacerbations, raise questions

Epeius Biotechnologies announces results of Rexin-G in chem-resistant metastatic soft tissue sarcoma and osteosarcoma

Epeius Biotechnologies announces results of Rexin-G in chem-resistant metastatic soft tissue sarcoma and osteosarcoma

Bionovo to present phase 1B trial results of BZL101 in metastatic breast cancer

Bionovo to present phase 1B trial results of BZL101 in metastatic breast cancer

XTL Biopharmaceuticals announces results from Bicifadine in diabetic neuropathic pain trial

XTL Biopharmaceuticals announces results from Bicifadine in diabetic neuropathic pain trial

Prana Biotechnology's compound could halt Alzheimer's pathology

Prana Biotechnology's compound could halt Alzheimer's pathology

Metabolex announces positive results from phase 2 trial of MBX-8025

Metabolex announces positive results from phase 2 trial of MBX-8025

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Medicsight seeks FDA 510(k) clearance to market ColonCAD software in the U.S.

Medicsight seeks FDA 510(k) clearance to market ColonCAD software in the U.S.

Two common cancer drugs prevent, reverse type 1 diabetes

Two common cancer drugs prevent, reverse type 1 diabetes

Gel Technologies raises $9 million

Gel Technologies raises $9 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.